We report on the synthesis and characterization of a series of low molar mass, high aspect ratio ether-imide compounds. All ether-imides were obtained by terminating the appropriate dianhydride, that is, pyromellitic dianhydride ( PMDA ), 1,4,5,8-naphthalenetetra-carboxylic dianhydride ( NDA ), 3,3‘,4,4‘-biphenyltetracarboxylic dianhydride ( BPDA ), and 3,3‘,4,4‘-oxydiphthalic dianhydride ( ODPA ), with three flexible aryl-ether tails of different chain lengths. Increasing the number of meta-substituted aryl-ether units reduces the melt transition temperatures and at the same time increases the solubility of the ether-imides. When the flexibility of the dianhydride moiety increases, the thermal behavior of the compounds becomes significantly more complex: The BPDA - and ODPA -based compounds form glasses and exhibit multiple crystal phases. Most compounds form isotropic melts upon heating; however, 2,7-bis(-4-phenoxy-phenyl)-benzo[ lmn ][3,8]phenanthroline-1,3,6,8-tetraone ( NDA-n 0 ) displays a smectic A (S A )-type texture when cooled from the isotropic phase, followed by what appears to be a smectic phase with a columnar arrangement of the mesogens inside the layers. Single-crystal X-ray diffraction analysis and cyclic voltammetry experiments indicate that the wholly aromatic ether-imides NDA and BPDA could be excellent candidates for n-type semiconductor applications.
No takes yet. Share an insight, caveat, or question.
Dingemans et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: